A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease

Journal of Clinical Investigation

Volumn 125, Issue 12, 2015, Pages 4483-4496

  Soret, Rodolphe ^a   Mennetrey, Mathilde ^a   Bergeron, Karl F ^a   Dariel, Anne ^b,c   Neunlist, Michel ^c   Grunder, Franziska ^d   Faure, Christophe ^d   Silversides, David W ^e   Pilon, Nicolas ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 6; COLLAGEN TYPE 6A4; FIBRONECTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENTERIC NEURAL CREST CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE INSERTION; HIRSCHSPRUNG DISEASE; MOUSE; NEURAL CREST CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL MOTION; CHROMOSOME 21; CLINICAL TRIAL; COLON; COMPLICATION; DISEASE MODEL; DOWN SYNDROME; GENETICS; HUMAN; INFANT; INNERVATION; METABOLISM; MULTICENTER STUDY; NEURAL CREST; NEWBORN; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CELL MOVEMENT; CHROMOSOMES, HUMAN, PAIR 21; COLLAGEN TYPE VI; COLON; DISEASE MODELS, ANIMAL; DOWN SYNDROME; EXTRACELLULAR MATRIX; HIRSCHSPRUNG DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MICE; MICE, TRANSGENIC; NEURAL CREST;

EID: 84948798325     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI83178     Document Type: Article

References (69)

1. Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol. 2012;9(5):286-294.
2. Anderson RB, Newgreen DF, Young HM. Neural crest and the development of the enteric nervous system. Adv Exp Med Biol. 2006;589:181-196.
3. Heanue TA, Pachnis V. Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studies. Nat Rev Neurosci. 2007;8(6):466-479.
4. Obermayr F, Hotta R, Enomoto H, Young HM. Development and developmental disorders of the enteric nervous system. Nat Rev Gastroenterol Hepatol. 2013;10(1):43-57.
5. Bergeron KF, Silversides DW, Pilon N. The developmental genetics of Hirschsprung's disease. Clin Genet. 2013;83(1):15-22.
6. Goldstein AM, Hofstra RM, Burns AJ. Building a brain in the gut: development of the enteric nervous system. Clin Genet. 2013;83(4):307-316.
7. Lake JI, Heuckeroth RO. Enteric nervous system development: migration, differentiation, and disease. Am J Physiol Gastrointest Liver Physiol. 2013;305(1):G1-G24.
8. Amiel J, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45(1):1-14.
9. Barlow A, de Graaff E, Pachnis V. Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron. 2003;40(5):905-916.
10. Alves MM, et al. Contribution of rare and common variants determine complex diseas-es-Hirschsprung disease as a model. Dev Biol. 2013;382(1):320-329.
11. Bergeron KF, et al. Male-biased aganglionic megacolon in the TashT mouse line due to perturbation of silencer elements in a large gene desert of chromosome 10. PLoS Genet. 2015;11(3):e1005093.
12. Jannot AS, et al. Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease. PLoS One. 2013;8(5):e62519.
13. Korbel JO, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci USA. 2009;106(29):12031-12036.
14. Li Y, Kido T, Garcia-Barcelo MM, Tam PK, Tabat-abai ZL, Lau YF. SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease. Hum Mol Genet. 2015;24(3):685-697.
15. Wallace AS, Tan MX, Schachner M, Anderson RB. L1cam acts as a modifier gene for members of the endothelin signalling pathway during enteric nervous system development. Neurogastroenterol Motil. 2011;23(11):e510-e522.
16. Hynes RO, Naba A. Overview of the matrisome-an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol. 2012;4(1):a004903.
17. Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786-801.
18. Mouw JK, Ou G, Weaver VM. Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol. 2014;15(12):771-785.
19. Breau MA, Dahmani A, Broders-Bondon F, Thi-ery JP, Dufour S. Beta1 integrins are required for the invasion of the caecum and proximal hind-gut by enteric neural crest cells. Development. 2009;136(16):2791-2801.
20. Breau MA, et al. Lack of beta1 integrins in enteric neural crest cells leads to a Hirschsprung-like phenotype. Development. 2006;133(9):1725-1734.
21. Akbareian SE, et al. Enteric neural crest-derived cells promote their migration by modifying their microenvironment through tenascin-C production. Dev Biol. 2013;382(2):446-456.
22. Barriga EH, Trainor PA, Bronner M, Mayor R. Animal models for studying neural crest development: is the mouse different? Development. 2015;142(9):1555-1560.
23. Knupp C, Squire JM. A new twist in the collagen story-the type VI segmented supercoil. EMBO J. 2001;20(3):372-376.
24. Fitzgerald J, Holden P, Hansen U. The expanded collagen VI family: new chains and new questions. Connect Tissue Res. 2013;54(6):345-350.
25. Gara SK, et al. Three novel collagen VI chains with high homology to the alpha3 chain. J Biol Chem. 2008;283(16):10658-10670.
26. Fitzgerald J, Rich C, Zhou FH, Hansen U. Three novel collagen VI chains, α4(VI), α5(VI), and α6(VI). J Biol Chem. 2008;283(29):20170-20180.
27. Gara SK, et al. Differential and restricted expres-sion of novel collagen VI chains in mouse. Matrix Biol. 2011;30(4):248-257.
28. Bonaldo P, Braghetta P, Zanetti M, Piccolo S, Volpin D, Bressan GM. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet. 1998;7(13):2135-2140.
29. Bonnemann CG. The collagen VI-related myop-athies: muscle meets its matrix. Nat Rev Neurol. 2011;7(7):379-390.
30. Dassah M, Almeida D, Hahn R, Bonaldo P, Wor-gall S, Hajjar KA. Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells. J Cell Sci. 2014;127(pt 4):828-844.
31. Pan TC, et al. A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. J Biol Chem. 2014;289(15):10293-10307.
32. Pan TC, et al. COL6A3 protein deficiency in mice leads to muscle and tendon defects similar to human collagen VI congenital muscular dystrophy. J Biol Chem. 2013;288(20):14320-14331.
33. Groulx JF, Gagne D, Benoit YD, Martel D, Basora N, Beaulieu JF. Collagen VI is a basement membrane component that regulates epithelial cell-fibronectin interactions. Matrix Biol. 2011;30(3):195-206.
34. Perris R, Kuo HJ, Glanville RW, Bronner-Fraser M. Collagen type VI in neural crest development: distribution in situ and interaction with cells ex vivo. Dev Dyn. 1993;198(2):135-149.
35. Sabatelli P, et al. Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts. Matrix Biol. 2001;20(7):475-486.
36. Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem. 1997;272(42):26522-26529.
37. Tillet E, et al. Recombinant expression and struc-tural and binding properties of α1(VI) and α2(VI) chains of human collagen type VI. Eur J Biochem. 1994;221(1):177-185.
38. Methot D, Reudelhuber TL, Silversides DW. Evaluation of tyrosinase minigene co-injection as a marker for genetic manipulations in transgenic mice. Nucleic Acids Res. 1995;23(22):4551-4556.
39. Moore SW, Johnson G. Acetylcholinesterase in Hirschsprung's disease. Pediatric surgery international. 2005;21(4):255-263.
40. Pilon N, Raiwet D, Viger RS, Silversides DW. Novel pre-and post-gastrulation expression of Gata4 within cells of the inner cell mass and migratory neural crest cells. Dev Dyn. 2008;237(4):1133-1143.
41. Mwizerwa O, Das P, Nagy N, Akbareian SE, Mably JD, Goldstein AM. Gdnf is mitogenic, neu-rotrophic, and chemoattractive to enteric neural crest cells in the embryonic colon. Dev Dyn. 2011;240(6):1402-1411.
42. Young HM, Hearn CJ, Farlie PG, Canty AJ, Thomas PQ, Newgreen DF. GDNF is a che-moattractant for enteric neural cells. Dev Biol. 2001;229(2):503-516.
43. Newgreen DF, Hartley L. Extracellular matrix and adhesive molecules in the early development of the gut and its innervation in normal and spotting lethal rat embryos. Acta Anat (Basel). 1995;154(4):243-260.
44. Edery P, et al. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994;367(6461):378-380.
45. Romeo G, et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994;367(6461):377-378.
46. Jiang Q, et al. Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability. Am J Hum Genet. 2015;96(4):581-596.
47. Fernandez RM, et al. Pathways systematically associated to Hirschsprung's disease. Orphanet J Rare Dis. 2013;8:187.
48. Tang CS, et al. Genome-wide copy number analysis uncovers a new HSCR gene: NRG3. PLoS Genet. 2012;8(5):e1002687.
49. Dixon JR, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485(7398):376-380.
50. Narendra V, et al. Transcription. CTCF establishes discrete functional chromatin domains at the Hox clusters during differentiation. Science. 2015;347(6225):1017-1021.
51. Nora EP, et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature. 2012;485(7398):381-385.
52. Lupianez DG, et al. Disruptions of topolog-ical chromatin domains cause pathogenic rewiring of gene-enhancer interactions. Cell. 2015;161(5):1012-1025.
53. Lupski JR. Genomic rearrangements and sporadic disease. Nat Genet. 2007;39(7 suppl):S43-S47.
54. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med. 2010;61:437-455.
55. Fujimoto T, Hata J, Yokoyama S, Mitomi T. A study of the extracellular matrix protein as the migration pathway of neural crest cells in the gut: analysis in human embryos with special reference to the pathogenesis of Hirschsprung's disease. J Pediatr Surg. 1989;24(6):550-556.
56. Rozario T, DeSimone DW. The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol. 2010;341(1):126-140.
57. De Bellard ME, Rao Y, Bronner-Fraser M. Dual function of Slit2 in repulsion and enhanced migration of trunk, but not vagal, neural crest cells. J Cell Biol. 2003;162(2):269-279.
58. Delabar JM, et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet. 1993;1(2):114-124.
59. Arnold S, et al. Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease association. Hum Mutat. 2009;30(5):771-775.
60. Fusaoka E, Inoue T, Mineta K, Agata K, Takeuchi K. Structure and function of primitive immuno-globulin superfamily neural cell adhesion molecules: a lesson from studies on planarian. Genes Cells. 2006;11(5):541-555.
61. Liu G, et al. DSCAM functions as a netrin receptor in commissural axon pathfinding. Proc Natl Acad Sci USA. 2009;106(8):2951-2956.
62. Ly A, Nikolaev A, Suresh G, Zheng Y, Tessier-Lavigne M, Stein E. DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1. Cell. 2008;133(7):1241-1254.
63. Gitton Y, et al. A gene expression map of human chromosome 21 orthologues in the mouse. Nature. 2002;420(6915):586-590.
64. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol. 1998;91(3):319-323.
65. Burns AJ, Thapar N. Neural stem cell therapies for enteric nervous system disorders. Nat Rev Gastroen terol Hepatol. 2014;11(5):317-328.
66. Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating The Mouse Embryo, A Laboratory Manual. 3rd ed. Cold Spring Harbor, New York, New York, USA: Cold Spring Harbor Laboratory Press; 2003.
67. Enomoto H, et al. GFR α1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron. 1998;21(2):317-324.
68. Nishiyama C, et al. Trans-mesenteric neural crest cells are the principal source of the colonic enteric nervous system. Nat Neurosci. 2012;15(9):1211-1218.
69. Lake JI, Tusheva OA, Graham BL, Heuckeroth RO. Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis. J Clin Invest. 2013;123(11):4875-4887.